IN VITRO AND IN VIVO EVALUATION OF EZETIMIBE FAST-DISSOLVING FILMS

Authors

  • V. AKASH Department of Pharmaceutical Technology, A. U. College of Pharmaceutical Sciences, Andhra University, Visakhapatnam-530003, A. P., India https://orcid.org/0009-0006-3087-101X
  • P. SHAILAJA Department of Pharmaceutical Technology, A. U. College of Pharmaceutical Sciences, Andhra University, Visakhapatnam-530003, A. P., India https://orcid.org/0000-0002-3796-7106

DOI:

https://doi.org/10.22159/ijap.2023v15i6.49110

Keywords:

Ezetimibe, Solvent casting, Fast-dissolving films, Plasticizers and superdisintegrants

Abstract

Objective: The goal of this investigation was to develop and evaluate Ezetimibe fast-dissolving films, which are used to treat hyperlipidemia and prevent cholesterol absorption.

Methods: The fast-dissolving Ezetimibe films were developed using the solvent casting method and included the following ingredients sodium carboxy methyl cellulose, HPMC E5, Polyvinyl Alcohol, Polyvinyl pyrrolidone which act as film-forming agents polyethylene glycol 600 and sodium starch glycolate, which acts as a superdisintegrant and plasticizer;, citric acid and stevia powder, which serves as a saliva stimulant and sweetener.

Results: The fast-dissolving films of Ezetimibe prepared with PVP K30 released the drug up to 99.87% within 5 min, which showed the increased solubility, dissolution rate, flexibility and tensile strength of the films when compared to formulation prepared with sodium carboxy methyl cellulose, HPMC E5, Polyvinyl Alcohol. The FTIR and DSC studies were conducted for pure drug, polymers and optimized formulation E11, which indicated that were no incompatibilities found between the drug and polymers used in the present studies. Scanning electron microscopy analysis was performed for pure drug, and optimized formulation E11 showed that they were no surface fractures and cracks in the films. The optimized formulation E11 was subjected to in vivo studies by using New Zealand Rabbits, and accelerated stability studies revealed that all the formulation is stable.

Conclusion: The current study reveals that fast-dissolving films formulated as a novel drug delivery technology can increase the solubility and dissolution rate of poorly water-soluble drug Ezetimibe.

Downloads

Download data is not yet available.

References

Chaudhary H, Gauri S, Rathee P, Kumar V. Development and optimization of fast dissolving oro-dispersible films of granisetron HCl using box–behnken statistical design. Bulletin of Faculty of Pharmacy Cairo University. 2013;51(2):193-201. doi: 10.1016/j.bfopcu.2013.05.002.

Thapa P, Thapa R, Budhathoki U, Thapa P. Solubility enhancement of domperidone fast disintegrating tablet using hydroxypropyl-β-cyclodextrin by inclusion complexation technique. Pharmacology and Pharmacy. 2014;05(3):238-49. doi: 10.4236/pp.2014.53031.

Raju S, Reddy PS, Kumar VA, Deepthi A, Reddy KS, Reddy PVM. Flash release oral films of metoclopramide hydrochloride for pediatric use: formulation and in vitro evaluation. J Chem Pharm Res. 2011;3(4):636-46.

Verma P, Thakur AS, Deshmukh K, Jha AK, Verma S. Routes of drug administration. Int J Pharm Stud Res. 2010;1(1):54-9.

El-Setouhy DA, Abd El-Malak NS. Formulation of a novel tianeptine sodium orodispersible film. AAPS PharmSciTech. 2010;11(3):1018-25. doi: 10.1208/s12249-010-9464-2, PMID 20532710.

Saurabh R, Malviya R, Sharma PK. Trends in a buccal film: formulation characterization, recent studies, and patents. Eur J Appl Sci. 2011;3(3):93-101. PMID 25657792.

Prabhu P, Malli R, Koland M, Vijaynarayana K, D’Souza U, Harish N. Formulation and evaluation of fast dissolving films of levocitirizine dihydrochloride. Int J Pharm Investig. 2011;1(2):99-104. doi: 10.4103/2230-973X.82417, PMID 23071928.

Bhalla N, Deep A, Goswami M. An overview of various approaches oral controlled drug delivery system via gastro-retention drug delivery system. Int Res J Pharm. 2012;3(4):128-33.

Flesch G, Muller P, Lloyd P. Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man. Eur J Clin Pharmacol. 1997;52(2):115-20. doi: 10.1007/s002280050259, PMID 9174680.

Abdelbary A, Bendas ER, Ramadan AA, Mostafa DA. Pharmaceutical and pharmacokinetic evaluation of a novel fast-dissolving film formulation of flupentixol dihydrochloride. AAPS PharmSciTech. 2014;15(6):1603-10. doi: 10.1208/s12249-014-0186-8, PMID 25142820.

Vidyadhara S, Sasidhar RLC, Balakrishna T, Vardhan MS. Formulation of rizatriptan benzoate fast dissolving buccal films by emulsion evaporation technique. Int J Pharm Investig. 2015;5(2):101-6. doi: 10.4103/2230-973X.153387, PMID 25838995.

Kailas K, Mali Remeth J, S Ghorpade VS, D Havaldar V, Havaldar Bhimrao K, S Dhane NS. Taste-masked oral fast-dissolving sublingual strips of rizatriptan benzoate for migraine therapy. Marmara Pharm J. 2017;21(2):235. doi: 10.12991/ marupj.300316.

TB, SV, Tegk M, AR, Rlc S. Formulation and evaluation of esomeprazole fast dissolving buccal films. Asian J Pharm Clin Res 2018;11(10). doi: 10.22159/ajpcr.2018.v11i10.27321.

Balakrishna T, Vidyadhara S, Murthy TEGK, Sasidhar RLC, Venkateswarao J. Formulation and evaluation of lansoprazole fast dissolving buccal films. Asian J Pharm. 2016;10(3):13-9.

Mosab A. Approaches to achieve an oral controlled release drug delivery system using polymers: a recent review. Int J Pharm Pharm Sci. 2015;7(7):16-21.

Bhyan B, Bhatt DC, Jangra S. Pharmacokinetic study in humans and in vitro evaluation of bioenhanced bilayer sublingual films for the management of acute migraine. Int J App Pharm. 2023;15(3):190-9. doi: 10.22159/ijap.2023v15i3.46684.

Yulianita R, Sopyan Iyan, Muchtaridi M. Forced degradation study of statins: a review. Int J App Pharm. 2018;10(6). doi: 10.22159/ijap.2018v10i6.29086.

Winarti L, Ameliana L, Nurahmanto D. Formula optimization of orally disintegrating tablet containing meloxicam nanoparticles. Indonesian J Pharm. 2017;28(1):53-64. doi: 10.14499/indonesianjpharm28iss1pp53.

Shinkar DM, Pooja S, Aher Parag KD, Maru AD. Formulation and in vitro evaluation of fast-dissolving tablet of verapamil hydrochloride. Int J Pharm Pharm Sci. 2018;10:93-9.

Dixit RP, Puthli SP. Oral strip technology: overview and future potential. J Control Release. 2009;139(2):94-107. doi: 10.1016/j.jconrel.2009.06.014, PMID 19559740.

Roy A, Arees R, Blr M. Formulation development of oral fast-dissolving films of rupatadine fumarate. Asian J Pharm Clin Res. 2020;13(11):67-72. doi: 10.22159/ajpcr.2020.v13i11.39185.

Pondugula SR, Ramana Murthy KV. Formulation and evaluation of oral fast-dissolving films of poorly soluble drug ezetimibe using transcutol HP. Indian J Pharm Educ Res. 2018;52(3).

Anwar S, Zaman M, Raja MAG, Mahmood A, Amjad MW. Rosuvastatin, perindopril and ezetimibe loaded instant release buccal films: development and in vitro characterization. J Appl Biomed. 2020;18(4):115-25. doi: 10.32725/jab.2020.015, PMID 34907764.

Bala R, Khanna S, Pawar P. Design optimization and in vitro-in vivo evaluation of orally dissolving strips of clobazam. J Drug Deliv. 2014;2014:392783. doi: 10.1155/2014/392783, PMID 25328709.

Published

07-11-2023

How to Cite

AKASH, V., & SHAILAJA, P. (2023). IN VITRO AND IN VIVO EVALUATION OF EZETIMIBE FAST-DISSOLVING FILMS. International Journal of Applied Pharmaceutics, 15(6), 108–117. https://doi.org/10.22159/ijap.2023v15i6.49110

Issue

Section

Original Article(s)